Is Faeth Therapeutics, Inc. overvalued?

Faeth Therapeutics, Inc. (FTH) — key valuation metrics and fundamentals.

No verdict

Price

$10.03

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$258.6M

Dividend yield

0.0%

Return on equity

-153.5%

Sector

Healthcare

Fair value compares FTH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks